Motion DNA, Ola Grimsby Institute Schedule Presentation for Aug. 29

***

Health/Medical Writers / Business Editors SCOTTSDALE, Ariz.--(BUSINESS WIRE)--MOTD-- Motion DNA Corp. (OTC: MOTD) has reached a tentative agreement with the Ola Grimsby Institute and is scheduled to present at the physical therapy school's conference in August. Under the terms of the agreement, the Ola Grimsby Institute is expected to provide educational support to current and future users of Motion DNA's equipment for physical therapists and other medical professionals. Motion DNA will provide access to its technology for instructors of the Ola Grimsby Institute. Motion DNA executives will give an initial presentation to students and instructors of the Ola Grimsby Institute on Aug. 29 in San Francisco. The demonstration is expected to lead to sales to students in the graduate school's continuing education program for physical therapists. A training and education session is currently planned for November at Motion DNA's headquarters in Scottsdale. The second session is scheduled for nine of the Ola Grimsby Institute's lead instructors. Future training and education sessions for students of the Ola Grimsby Institute will be conducted by instructors of the leading physical therapy education group. Motion DNA has utilized research data provided by the Ola Grimsby Institute to speed up development of its system for individual and multiple joint range of motion analysis. All press releases may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products, which we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. KEYWORD: CALIFORNIA ARIZONA INDUSTRY KEYWORD: MEDICAL DEVICES SPORTS EDUCATION MARKETING AGREEMENTS SOURCE: Motion DNA Corp. CONTACT INFORMATION: Equitilink, LLC (Investor Relations) 877-788-1940 or Motion DNA Corp., Scottsdale 480-425-7734 or 877-425-7734 info@motiondnacorp.com

------------------
Due Da Due......But Be Quick About It!!!!!

Motion DNA to Tackle Injury Prevention in the Midwest!

SCOTTSDALE, Ariz., Aug 18, 2004 (BUSINESS WIRE) -- Motion DNA Corp. (OTC: MOTD) announced today plans to open a new office in Westfield, Ind. The new offices are being put in place in preparation for the anticipated closing of service agreements with major university and high school athletic programs in the area.
"It makes good business sense for us to place offices strategically near any large base of clients," said Zig Ziegler, president of Motion DNA Corp. "We have spent a while cultivating relationships with several clients in the area and they want to begin utilizing our services immediately upon signing."

Just north of Indianapolis, the Westfield site will be used as a hub for Motion DNA's mobile, diagnostic technicians to service clients in the Chicago, Indianapolis, Louisville, Ky., and Cincinnati areas. The company plans to add offices in each of those cities by the end of 2004.

Motion DNA Corp. provides diagnostic testing for medical professionals and sports organizations. Motion DNA's co-branded biomechanical analyses and detailed reports provide its customers with solutions for preventing injuries, identifying physical limitations, diagnosing pre-existing injuries related to biomechanics, and improving physical activity levels. For more information about Motion DNA, visit www.motiondnacorp.com.

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products, which we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets.